These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 659012)

  • 21. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids.
    Kharitonov SA; Rajakulasingam K; O'Connor B; Durham SR; Barnes PJ
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):58-64. PubMed ID: 9003212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized antigen challenge of the nasal mucosa.
    Flowers BK; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1990 Dec; 116(12):1407-10. PubMed ID: 2248741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma.
    Buckle FG; Cohen AB
    J Allergy Clin Immunol; 1975 Apr; 55(4):213-21. PubMed ID: 1123493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
    Wuestenberg EG; Hauswald B; Huettenbrink KB
    Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free histamine in nasal polyp fluid.
    Drake-Lee AB; Bickerton R; McLaughlan P
    Rhinology; 1984 Jun; 22(2):133-8. PubMed ID: 6463530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kininogens in nasal secretions after allergen challenge.
    Baumgarten CR; Naclerio RM; Togias AG; Lichtenstein LM; Norman PS; Proud D
    Adv Exp Med Biol; 1986; 198 Pt B():189-92. PubMed ID: 2433913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection.
    Eggleston PA; Hendley JO; Gwaltney JM
    Acta Otolaryngol Suppl; 1984; 413():25-35. PubMed ID: 6099951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E in the secretions of allergic rhinitis.
    Okazki T; Reisman RE; Arbesman CE
    Prostaglandins; 1977 Apr; 13(4):681-90. PubMed ID: 854578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.
    Mosimann BL; White MV; Hohman RJ; Goldrich MS; Kaulbach HC; Kaliner MA
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):95-104. PubMed ID: 7687608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.
    Suzuki Y; Inoue T; Yamamoto A; Sugimoto Y
    Biol Pharm Bull; 2011; 34(4):507-10. PubMed ID: 21467637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of terfenadine on substance P and vasoactive intestinal polypeptide concentrations in nasal secretions from patients with nasal allergy.
    Takeyama M; Mori K; Morikawa N; Asakura S; Chaen T; Watanabe N; Mogi G
    J Pharm Pharmacol; 1994 Jan; 46(1):41-5. PubMed ID: 7515418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction.
    Jarjour NN; Calhoun WJ; Schwartz LB; Busse WW
    Am Rev Respir Dis; 1991 Jul; 144(1):83-7. PubMed ID: 2064143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo detection of a novel macrophage-derived protein involved in the regulation of nasal mucus-like glycoconjugate secretion.
    Sperber K; Sylvester C; Gollub E; Goswami S; Kalb TH; Druce H; Rutledge J; Marom Z
    J Allergy Clin Immunol; 1993 Oct; 92(4):581-8. PubMed ID: 8409118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mast cells in the nasal secretions of patients with chronic rhinitis and rhinosinusitis].
    Gerber VKh; Elykomov AA
    Vestn Otorinolaringol; 1973; 34(4):52-6. PubMed ID: 4713900
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of 5 -hydroxy-indolacetic-acid ( 5 -HIAA) in urine and nasal mucus in provoked allergic rhinitis.
    Celestino D; Drettner B; Fagerberg E; Hjelm M
    Acta Allergol; 1972 Sep; 27(4):264-72. PubMed ID: 4678788
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of vascular endothelial growth factor on nasal vascular permeability.
    Matsune S; Ohori J; Yoshifuku K; Kurono Y
    Laryngoscope; 2010 Apr; 120(4):844-8. PubMed ID: 20213656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrolytes and proteins of nasal secretion in mucoviscidosis].
    Crifò S; Antonelli M
    Boll Soc Ital Biol Sper; 1971 Jun; 47(11):330-3. PubMed ID: 5117590
    [No Abstract]   [Full Text] [Related]  

  • 39. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
    Greiff L; Persson CG; Svensson C; Enander I; Andersson M
    J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.